Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversion
Authors:
- Jason D. SimmonsJSJason D. Simmons
- Phu T. VanPVPhu T. Van
- Catherine M. SteinCSCatherine M. Stein
- Violet ChihotaVCViolet Chihota
- Thobani NtshiqaTNThobani Ntshiqa
- Pholo MaenetjePMPholo Maenetje
- Glenna J. PetersonGPGlenna J. Peterson
- Anthony ReynoldsARAnthony Reynolds
- Penelope BenchekPBPenelope Benchek
- Kavindhran VelenKVKavindhran Velen
- Katherine L. FieldingKFKatherine L. Fielding
- Alison D. GrantAGAlison D. Grant
Open Access
- 15 July 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (14)
Abstract
After extensive exposure to Mycobacterium tuberculosis (Mtb), most individuals acquire latent Mtb infection (LTBI) defined by a positive tuberculin skin test (TST) or interferon-γ release assay (IGRA). To identify mechanisms of resistance to Mtb infection, we compared transcriptional profiles from highly exposed contacts who resist TST/IGRA conversion (resisters, RSTRs) and controls with LTBI using RNAseq. Gene sets related to carbon metabolism and free fatty acid (FFA) transcriptional responses enriched across 2 independent cohorts suggesting RSTR and LTBI monocytes have distinct activation states. We compared intracellular Mtb replication in macrophages treated with FFAs and found that palmitic acid (PA), but not oleic acid (OA), enhanced Mtb intracellular growth. This PA activity correlated with its inhibition of proinflammatory cytokines in Mtb-infected cells. Mtb growth restriction in PA-treated macrophages was restored by activation of AMP kinase (AMPK), a central host metabolic regulator known to be inhibited by PA. Finally, we genotyped AMPK variants and found 7 SNPs in PRKAG2, which encodes the AMPK-γ subunit, that strongly associated with RSTR status. Taken together, RSTR and LTBI phenotypes are distinguished by FFA transcriptional programs and by genetic variation in a central metabolic regulator, which suggests immunometabolic pathways regulate TST/IGRA conversion.Keywords
Funding Information
- National Institutes of Health (K08AI143926)
- National Institutes of Health (T32AI007044)
- National Institutes of Health (R01AI124348)
- National Institutes of Health (U01AI115642)
- National Institutes of Health (NO1AI70022)
- Bill and Melinda Gates Foundation (OPP1151836)
- South African Medical Research Council (ACT4TB/HIV)
- National Institutes of Health (K24AI137310)
This publication has 90 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Camera: a competitive gene set test accounting for inter-gene correlationNucleic Acids Research, 2012
- Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesityJournal of Clinical Investigation, 2011
- Differential Regulation of Dihydroceramide Desaturase by Palmitate versus Monounsaturated Fatty AcidsJournal of Biological Chemistry, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Electron Transport Chain-dependent and -independent Mechanisms of Mitochondrial H2O2 Emission during Long-chain Fatty Acid OxidationJournal of Biological Chemistry, 2010
- Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosisJournal of Experimental Medicine, 2009
- Foamy macrophages and the progression of the human tuberculosis granulomaNature Immunology, 2009
- Mycobacterial persistence requires the utilization of host cholesterolProceedings of the National Academy of Sciences, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005